Gary Pansegrau

Gary Pansegrau

UNVERIFIED PROFILE

Are you Gary Pansegrau?   Register this Author

Register author
Gary Pansegrau

Gary Pansegrau

Publications by authors named "Gary Pansegrau"

Are you Gary Pansegrau?   Register this Author

6Publications

-Reads

Costs and Benefits of Extended Endocrine Strategies for Premenopausal Breast Cancer.

J Natl Compr Canc Netw 2017 Aug;15(8):1015-1021

From the Department of Obstetrics and Gynecology, Division of Surgical Oncology, University of British Columbia, and BC Cancer Agency, Vancouver, British Columbia; Department of Medical Oncology, Fraser Valley Cancer Centre, BC Cancer Agency, Surrey, British Columbia; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, McGill University, Montreal, Quebec; and Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

View Article
August 2017

Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.

Cancer Treat Rev 2017 Apr 22;55:26-35. Epub 2017 Feb 22.

Departments of Obstetrics and Gynecology and Surgical Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article
April 2017

Long-term consequences of ovarian ablation for premenopausal breast cancer.

Breast Cancer Res Treat 2016 06 28;157(3):565-73. Epub 2016 May 28.

Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.

View Article
June 2016

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.

Obstet Gynecol 2013 Jan;121(1):14-24

University of British Columbia and BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article
January 2013

Trastuzumab-associated peripheral vascular toxicity.

J Clin Oncol 2007 Apr;25(11):1438-40

British Columbia Cancer Agency, Fraser Valley Centre, Surrey, British Columbia, Canada.

View Article
April 2007

Lymph-node-negative oestrogen-receptor-positive breast cancer.

Lancet 2004 Sep 4-10;364(9437):820-1

British Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6.

View Article
September 2004